Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin studies this year.

Brazil's data protection watchdog ANDP has banned Tools for Humanity from offering payment for iris scanning in the country.

Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump. Newsweek has contacted OpenAI and the White House for comment via email.

Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT reports.

OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI agent that can act

The latest spat began after Altman joined Trump, SoftBank CEO Masayoshi Son, and Oracle Chairman Larry Ellison in a White House ceremony on Tuesday to announce the launch of Stargate, a $500 billion venture to advance the United States’ artificial intelligence infrastructure.

"I genuinely respect your accomplishments and think you are the most inspiring entrepreneur of our time," Altman wrote in an X post to Musk.

Tensions between technology leaders Elon Musk and OpenAI CEO Sam Altman were on full display this week after the Tesla CEO slammed the new artificial intelligence (AI) infrastructure project,

Though Altman said he likely wouldn’t agree with Trump on “everything,” the OpenAI CEO said he believes “he will be incredible for the country in many ways.”

Elon Musk is clashing with OpenAI CEO Sam Altman over the Stargate artificial intelligence infrastructure project touted by President Donald Trump, the latest in a feud between the two billionaires that started on OpenAI’s board and is now testing

President Donald Trump spoke with OpenAI CEO Sam Altman by phone Friday, ahead of the AI infrastructure announcement, CNBC has learned.